Sakai, Japan

Jun Saito

This inventor holds 1 USPTO granted patent. Top assignee: Kyowa Hakko Kirin Co., Limited. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jun Saito. Retrieved from https://idiyas.com/inventor/jun-saito-1z6e0ure

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Jun Saito in Neutrophilic Inflammatory Diseases

Introduction

Jun Saito is an accomplished inventor based in Sakai, Japan. He has made significant contributions to the field of medical science, particularly in the development of therapeutic agents for inflammatory diseases. His work is recognized for its potential impact on healthcare and treatment methodologies.

Latest Patents

Jun Saito holds a patent for a preventive and/or therapeutic agent for neutrophilic inflammatory diseases. This invention comprises a bicyclic heterocyclic compound that serves as an active ingredient. The compound is represented by a specific formula, which includes various chemical components that enhance its efficacy in treating such diseases.

Career Highlights

Saito is associated with Kyowa Hakko Kirin Co., Limited, a company known for its innovative approaches in biotechnology and pharmaceuticals. His work at the company has been pivotal in advancing research and development in therapeutic solutions.

Collaborations

Jun Saito collaborates with notable colleagues, including Kyoichiro Iida and Nobumasa Otsubo. Their teamwork exemplifies the collaborative spirit in scientific research, contributing to the advancement of medical treatments.

Conclusion

Jun Saito's innovative work in developing therapeutic agents for neutrophilic inflammatory diseases showcases his dedication to improving healthcare. His contributions are vital in the ongoing quest for effective treatments in the medical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…